VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization
Alternative splicing leads to the secretion of multiple forms of vascular endothelial growth factor-A (VEGF-A) that differ in their activity profiles with respect to neovascularization. FSAP (factor VII activating protease) is the zymogen form of a plasma protease that is activated (FSAPa) upon tiss...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-11-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/8/11/1396 |
| _version_ | 1827834386595184640 |
|---|---|
| author | Özgür Uslu Joerg Herold Sandip M. Kanse |
| author_facet | Özgür Uslu Joerg Herold Sandip M. Kanse |
| author_sort | Özgür Uslu |
| collection | DOAJ |
| description | Alternative splicing leads to the secretion of multiple forms of vascular endothelial growth factor-A (VEGF-A) that differ in their activity profiles with respect to neovascularization. FSAP (factor VII activating protease) is the zymogen form of a plasma protease that is activated (FSAPa) upon tissue injury via the release of histones. The purpose of the study was to determine if FSAPa regulates VEGF-A activity in vitro and in vivo. FSAP bound to VEGF<sub>165</sub>, but not VEGF<sub>121</sub>, and VEGF<sub>165</sub> was cleaved in its neuropilin/proteoglycan binding domain. VEGF<sub>165</sub> cleavage did not alter its binding to VEGF receptors but diminished its binding to neuropilin. The stimulatory effects of VEGF<sub>165</sub> on endothelial cell proliferation, migration, and signal transduction were not altered by FSAP. Similarly, proliferation of VEGF receptor-expressing BAF3 cells, in response to VEGF<sub>165</sub>, was not modulated by FSAP. In the mouse matrigel model of angiogenesis, FSAP decreased the ability of VEGF<sub>165</sub>, basic fibroblast growth factor (bFGF), and their combination, to induce neovascularization. Lack of endogenous FSAP in mice did not influence neovascularization. Thus, FSAP inhibited VEGF<sub>165</sub>-mediated angiogenesis in the matrigel model in vivo, where VEGF’s interaction with the matrix and its diffusion are important. |
| first_indexed | 2024-03-12T05:49:05Z |
| format | Article |
| id | doaj.art-f3a0af665e00426197691551fdf96282 |
| institution | Directory Open Access Journal |
| issn | 2073-4409 |
| language | English |
| last_indexed | 2024-03-12T05:49:05Z |
| publishDate | 2019-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj.art-f3a0af665e00426197691551fdf962822023-09-03T05:21:43ZengMDPI AGCells2073-44092019-11-01811139610.3390/cells8111396cells8111396VEGF-A-Cleavage by FSAP and Inhibition of Neo-VascularizationÖzgür Uslu0Joerg Herold1Sandip M. Kanse2Institute for Biochemistry, Justus-Liebig-University Giessen, 35392 Giessen, GermanyDepartment of Angiology, Clinic for Vascular Medicine, Klinikum Darmstadt, 64283 Darmstadt, GermanyInstitute for Basic Medical Sciences, University of Oslo, Sognvannsveien 9, 0372 Oslo, NorwayAlternative splicing leads to the secretion of multiple forms of vascular endothelial growth factor-A (VEGF-A) that differ in their activity profiles with respect to neovascularization. FSAP (factor VII activating protease) is the zymogen form of a plasma protease that is activated (FSAPa) upon tissue injury via the release of histones. The purpose of the study was to determine if FSAPa regulates VEGF-A activity in vitro and in vivo. FSAP bound to VEGF<sub>165</sub>, but not VEGF<sub>121</sub>, and VEGF<sub>165</sub> was cleaved in its neuropilin/proteoglycan binding domain. VEGF<sub>165</sub> cleavage did not alter its binding to VEGF receptors but diminished its binding to neuropilin. The stimulatory effects of VEGF<sub>165</sub> on endothelial cell proliferation, migration, and signal transduction were not altered by FSAP. Similarly, proliferation of VEGF receptor-expressing BAF3 cells, in response to VEGF<sub>165</sub>, was not modulated by FSAP. In the mouse matrigel model of angiogenesis, FSAP decreased the ability of VEGF<sub>165</sub>, basic fibroblast growth factor (bFGF), and their combination, to induce neovascularization. Lack of endogenous FSAP in mice did not influence neovascularization. Thus, FSAP inhibited VEGF<sub>165</sub>-mediated angiogenesis in the matrigel model in vivo, where VEGF’s interaction with the matrix and its diffusion are important.https://www.mdpi.com/2073-4409/8/11/1396factor vii activating proteasehabp2vegfmatrigelneo-vascularizationhind limb ischemia |
| spellingShingle | Özgür Uslu Joerg Herold Sandip M. Kanse VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization Cells factor vii activating protease habp2 vegf matrigel neo-vascularization hind limb ischemia |
| title | VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization |
| title_full | VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization |
| title_fullStr | VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization |
| title_full_unstemmed | VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization |
| title_short | VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization |
| title_sort | vegf a cleavage by fsap and inhibition of neo vascularization |
| topic | factor vii activating protease habp2 vegf matrigel neo-vascularization hind limb ischemia |
| url | https://www.mdpi.com/2073-4409/8/11/1396 |
| work_keys_str_mv | AT ozguruslu vegfacleavagebyfsapandinhibitionofneovascularization AT joergherold vegfacleavagebyfsapandinhibitionofneovascularization AT sandipmkanse vegfacleavagebyfsapandinhibitionofneovascularization |